Distinguished Expert, Honorary Director，
Guangzhou University of Chinese Medicine Jinshazhou Hospital

Prof. Wang Yi-Ming

• Expert of the Medical High-Level Talent Program of the National Health Commission of the People's Republic of China

• Consultant of Guangzhou Regional Quality Control Center for Tumor Radiation Therapy

• Senior Consultant of the Grassroots Tumor Prevention, Treatment and Rehabilitation Professional Committee, Guangdong Provincial Association of Geriatric Health Care

• Member of the Ethics Committee, Guangdong Association for Thoracic Tumor Prevention and Treatment (GASTO)

• Former Standing Editorial Board Member of Chinese Journal of Cancer Prevention and Treatment

• Former Standing Editorial Board Member of The Journal of Practical Medicine

As of 2024, we have successfully performed over 5,000 cases of malignant tumor radiotherapy. Our clinical focus areas include:
IntensityModulated Radiotherapy (IMRT) Combined with Targeted Therapy for Nasopharyngeal Carcinomapatient.varian.com Stereotactic Body Radiation Therapy (SBRT) for Lung CancerThe Society of Thoracic Surgeons Salvage Radiotherapy for Postoperative Recurrent Cervical Cancer Partial Breast Irradiation (PBI) after BreastConserving Surgery We have innovatively proposed the ThreeStage Assessment Approach, which divides the tumor radiotherapy process into the Localization Phase, Planning Phase, and Irradiation Phase. By leveraging artificial intelligence to assist in target volume delineation, the localization error is controlled within 1 mm. The "Clinical Application Research on Spatially Fractionated Radiation Therapy (SFRT)" launched in 2024 has been included in the Guangdong Provincial Key Medical Technology Promotion Program

Dr. Liu-Ying

Director of Oncology Ward

Expertise: Comprehensive treatment of hepatocellular carcinoma, cholangiocarcinoma, lung cancer, colorectal cancer; specialized in melanoma & liver metastasis; proficient in MWA, RFA, cryoablation, radioactive seed implantation.

• Participant in 2 Guangdong Provincial Sci-Tech Research Projects

• Contributor to Expert Consensus for Thermal Ablation of Primary and Metastatic Lung Tumors (2014) (published in Chinese Journal of Lung Cancer)

• Compiler of supporting textbooks for tumor ablation standardized training: Selected Cases of Microwave Ablation for Lung/Liver Tumors

Dr. Wei-Xiaping

Deputy Director & Chief Radiation Physicist, Radiation Oncology Center

Member of the International Association for the Study of Lung Cancer (IASLC) / Member of the Radiation Physics Professional Committee, Guangdong Provincial Association of Traditional Chinese Medicine / 

• Image-Guided Radiation Therapy (IGRT)

• Tumor Motion Management & Respiratory Gating

• Stereotactic Body Radiotherapy (SBRT)

• Proton Beam Therapy

Dr. Zhang-Yanjun

Master's Supervisor, MD, Chief Physician

Having been engaged in clinical work of tumor imaging diagnosis and radiation oncology for 28 years, he is proficient in radiation therapy for various malignant tumors including lung cancer, liver cancer, nasopharyngeal carcinoma, head and neck tumors, esophageal cancer, breast cancer, rectal cancer, cervical cancer, prostate cancer, lymphoma, and central nervous system tumors. He has rich clinical experience in imaging diagnosis and is skilled in radiation therapy for primary and secondary tumors in both children and adults; especially, he has extensive clinical experience in radiation therapy for neurological tumors in children and adults as well as stereotactic radiation therapy. He has served as a visiting scholar twice at top-tier cancer radiation therapy hospitals in the United States for study and work. He has published 46 theses on international tumor diagnosis and treatment in domestic and foreign core medical journals and at international conferences.

Dr. Yao-Zhongping

Director of Minimally Invasive Interventional Ward

With 20 years of dedicated practice in oncology, specialize in vascular and non-vascular minimally invasive treatments as well as comprehensive management for solid tumors, including lung cancer, breast cancer, hepatobiliary tumors, and gastrointestinal tumors. possess distinct advantages in minimally invasive interventional therapy, a core area of my clinical focus. Backed by solid technical proficiency and rigorous clinical practice, have successfully performed thousands of interventional procedures across various tumor types, accumulating profound hands-on experience in precise, patient-centered treatment. Committed to integrating academic research with clinical practice, have participated in compiling medical monographs and published numerous peer-reviewed professional papers. These contributions have provided valuable theoretical support for advancing the standardization and innovative development of interventional oncology.

Internationally Aligned Oncology Protocols

- EVIDENCE-BASED CANCER CARE

Our oncology team continuously updates treatment protocols based on current international clinical evidence, radiation oncology advancements, and multidisciplinary case reviews.

Multidisciplinary Treatment (MDT)

MDT Review for Complex Cases

Each treatment plan is reviewed collaboratively by specialists in radiation oncology, medical oncology, and integrative cancer medicine to ensure a more personalised and comprehensive approach.

Guided by Modern Oncology Standards